nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antagonists of IAP proteins as cancer therapeutics
|
Dynek, Jasmin N. |
|
2013 |
332 |
2 |
p. 206-214 9 p. |
artikel |
2 |
Antibody-based fusion proteins to target death receptors in cancer
|
de Bruyn, Marco |
|
2013 |
332 |
2 |
p. 175-183 9 p. |
artikel |
3 |
BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
|
Del Gaizo Moore, Victoria |
|
2013 |
332 |
2 |
p. 202-205 4 p. |
artikel |
4 |
Caspase-8 as a therapeutic target in cancer
|
Stupack, Dwayne G. |
|
2013 |
332 |
2 |
p. 133-140 8 p. |
artikel |
5 |
Combating apoptosis and multidrug resistant cancers by targeting lysosomes
|
Groth-Pedersen, Line |
|
2013 |
332 |
2 |
p. 265-274 10 p. |
artikel |
6 |
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
|
Roos, Wynand P. |
|
2013 |
332 |
2 |
p. 237-248 12 p. |
artikel |
7 |
Editorial
|
Fulda, Simone |
|
2013 |
332 |
2 |
p. 132- 1 p. |
artikel |
8 |
Editorial Board
|
|
|
2013 |
332 |
2 |
p. ii- 1 p. |
artikel |
9 |
Engineering death receptor ligands for cancer therapy
|
Wajant, Harald |
|
2013 |
332 |
2 |
p. 163-174 12 p. |
artikel |
10 |
Featuring the guest editor
|
Fulda, Simone |
|
2013 |
332 |
2 |
p. 131- 1 p. |
artikel |
11 |
FLIP: A flop for execution signals
|
Subramaniam, Kothandharaman |
|
2013 |
332 |
2 |
p. 151-155 5 p. |
artikel |
12 |
Pulling the plug on a cancer cell by eliminating XIAP with AEG35156
|
LaCasse, Eric C. |
|
2013 |
332 |
2 |
p. 215-224 10 p. |
artikel |
13 |
Radiotherapy and TRAIL for cancer therapy
|
Niemoeller, Olivier M. |
|
2013 |
332 |
2 |
p. 184-193 10 p. |
artikel |
14 |
Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL
|
Holland, Pamela M. |
|
2013 |
332 |
2 |
p. 156-162 7 p. |
artikel |
15 |
Targeting apoptosis pathways by Celecoxib in cancer
|
Jendrossek, Verena |
|
2013 |
332 |
2 |
p. 313-324 12 p. |
artikel |
16 |
Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy
|
von Schwarzenberg, Karin |
|
2013 |
332 |
2 |
p. 295-303 9 p. |
artikel |
17 |
Targeting apoptosis pathways in cancer by Chinese medicine
|
Li-Weber, Min |
|
2013 |
332 |
2 |
p. 304-312 9 p. |
artikel |
18 |
Targeting apoptosis pathways in cancer stem cells
|
Signore, Michele |
|
2013 |
332 |
2 |
p. 374-382 9 p. |
artikel |
19 |
Targeting apoptosis pathways in childhood malignancies
|
Fulda, Simone |
|
2013 |
332 |
2 |
p. 369-373 5 p. |
artikel |
20 |
Targeting apoptosis pathways in glioblastoma
|
Eisele, Günter |
|
2013 |
332 |
2 |
p. 335-345 11 p. |
artikel |
21 |
Targeting apoptosis pathways in lung cancer
|
Pore, Milind M. |
|
2013 |
332 |
2 |
p. 359-368 10 p. |
artikel |
22 |
Targeting apoptosis pathways in pancreatic cancer
|
Arlt, Alexander |
|
2013 |
332 |
2 |
p. 346-358 13 p. |
artikel |
23 |
Targeting apoptosis proteins in hematological malignancies
|
Droin, Nathalie |
|
2013 |
332 |
2 |
p. 325-334 10 p. |
artikel |
24 |
Targeting c-FLIP in cancer
|
Shirley, Sarah |
|
2013 |
332 |
2 |
p. 141-150 10 p. |
artikel |
25 |
Targeting ER stress induced apoptosis and inflammation in cancer
|
Verfaillie, Tom |
|
2013 |
332 |
2 |
p. 249-264 16 p. |
artikel |
26 |
Targeting heat shock proteins in cancer
|
Jego, Gaëtan |
|
2013 |
332 |
2 |
p. 275-285 11 p. |
artikel |
27 |
Targeting p73 in cancer
|
Maas, Anna-Maria |
|
2013 |
332 |
2 |
p. 229-236 8 p. |
artikel |
28 |
Targeting survivin in cancer
|
Altieri, Dario C. |
|
2013 |
332 |
2 |
p. 225-228 4 p. |
artikel |
29 |
Targeting the ceramide system in cancer
|
Henry, Brian |
|
2013 |
332 |
2 |
p. 286-294 9 p. |
artikel |
30 |
Translating TRAIL-receptor targeting agents to the clinic
|
den Hollander, Martha W. |
|
2013 |
332 |
2 |
p. 194-201 8 p. |
artikel |